Molecular Simulations of Amyloid Structures, Toxicity, and Inhibition

被引:24
作者
Zhang, Mingzhen [1 ]
Ren, Baiping [1 ]
Chen, Hong [1 ]
Sun, Yan [2 ,3 ]
Ma, Jie [1 ,4 ]
Jiang, Binbo [1 ,5 ]
Zheng, Jie [1 ]
机构
[1] Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA
[2] Tianjin Univ, Sch Chem Engn & Technol, Dept Biochem Engn, Minist Educ, Tianjin 300072, Peoples R China
[3] Tianjin Univ, Sch Chem Engn & Technol, Key Lab Syst Bioengn, Minist Educ, Tianjin 300072, Peoples R China
[4] Tongji Univ, State Key Lab Pollut Control & Resource Reuse, Sch Environm Sci & Engn, Shanghai 200092, Peoples R China
[5] Zhejiang Univ, Coll Chem & Biol Engn, Hangzhou 310027, Zhejiang, Peoples R China
基金
中国国家自然科学基金; 美国国家科学基金会;
关键词
aggregation; amyloid toxicity; amyloid inhibition; molecular modeling; neurodegenerative diseases; SELF-ASSEMBLED HEXAPEPTIDES; BETA-PROTEIN FIBRILLATION; ALZHEIMER TRANSGENIC MICE; ION-CHANNEL ACTIVITY; SOLID-STATE NMR; A-BETA; PEPTIDE AGGREGATION; ALPHA-SYNUCLEIN; DYNAMICS SIMULATIONS; MEMBRANE DISRUPTION;
D O I
10.1002/ijch.201600075
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The misfolding and aggregation of proteins and peptides into amyloid fibrils are believed to be responsible for the dysfunction and death of neuron cells in many neurodegenerative diseases. Resolving the atomic structures of amyloid peptides at different aggregation stages by molecular simulations has opened new ways to probe the molecular mechanisms of amyloid aggregation, toxicity, and inhibition, as well as to validate computational data with available experimental ones. In this review article, we summarize some recent and important findings on: 1) a number of atomic structures of amyloid oligomers with typical beta-sheet-rich conformations, related to amyloid aggregation; 2) different amyloid peptide-induced membrane-disruption mechanisms, related to amyloid toxicity; and 3) rational design of different amyloid inhibitors capable of preventing amyloid aggregation and toxicity, related to amyloid inhibition. All these findings will provide some mechanistic implications for molecular mechanisms of amyloid aggregation, toxicity, and inhibition, which are fundamentally and practically important for the treatment of amyloid diseases.
引用
收藏
页码:586 / 601
页数:16
相关论文
共 149 条
  • [1] Dissecting the Role of Single Regions of an IAPP Mimic and IAPP in Inhibition of Aβ40 Amyloid Formation and Cytotoxicity
    Andreetto, Erika
    Yan, Li-Mei
    Caporale, Andrea
    Kapurniotu, Aphrodite
    [J]. CHEMBIOCHEM, 2011, 12 (09) : 1313 - 1322
  • [2] Plasma membrane cholesterol controls the cytotoxicity of Alzheimer's disease AβP (1-40) and (1-42) peptides
    Arispe, N
    Doh, M
    [J]. FASEB JOURNAL, 2002, 16 (12) : 1526 - 1536
  • [3] The novel β-secretase inhibitor KMI-429 reduces amyloid β peptide production in amyloid precursor protein transgenic and wild-type mice
    Asai, M
    Hattori, C
    Iwata, N
    Saido, TC
    Sasagawa, N
    Szabó, B
    Hashimoto, Y
    Maruyama, K
    Tanuma, S
    Kiso, Y
    Ishiura, S
    [J]. JOURNAL OF NEUROCHEMISTRY, 2006, 96 (02) : 533 - 540
  • [4] Designing peptide inhibitors for oligomerization and toxicity of Alzheimer's β-amyloid peptide
    Austen, Brian M.
    Paleologou, Katerina E.
    Ali, Sumaya A. E.
    Qureshi, Mohamed M.
    Allsop, David
    El-Agnaf, Omar M. A.
    [J]. BIOCHEMISTRY, 2008, 47 (07) : 1984 - 1992
  • [5] The early stages of amyloid formation: Biophysical and structural characterization of human calcitonin pre-fibrillar assemblies
    Avidan-Shpalter, Carmit
    Gazit, Ehud
    [J]. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2006, 13 (04): : 216 - 225
  • [6] Imaging of amyloid-β deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy
    Backskai, BJ
    Kajdasz, ST
    Christie, RH
    Carter, C
    Games, D
    Seubert, P
    Schenk, D
    Hyman, BT
    [J]. NATURE MEDICINE, 2001, 7 (03) : 369 - 372
  • [7] Globular amyloid β-peptide1-42 oligomer -: a homogenous and stable neuropathological protein in Alzheimer's disease
    Barghorn, S
    Nimmrich, V
    Striebinger, A
    Krantz, C
    Keller, P
    Janson, B
    Bahr, M
    Schmidt, M
    Bitner, RS
    Harlan, J
    Barlow, E
    Ebert, U
    Hillen, H
    [J]. JOURNAL OF NEUROCHEMISTRY, 2005, 95 (03) : 834 - 847
  • [8] Strategies for the Inhibition of Protein Aggregation in Human Diseases
    Bartolini, Manuela
    Andrisano, Vincenza
    [J]. CHEMBIOCHEM, 2010, 11 (08) : 1018 - 1035
  • [9] Conversion of non-fibrillar β-sheet oligomers into amyloid fibrils in Alzheimer's disease amyloid peptide aggregation
    Benseny-Cases, Nuria
    Cocera, Mercedes
    Cladera, Josep
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 361 (04) : 916 - 921
  • [10] Inter-Species Cross-Seeding: Stability and Assembly of Rat - Human Amylin Aggregates
    Berhanu, Workalemahu M.
    Hansmann, Ulrich H. E.
    [J]. PLOS ONE, 2014, 9 (05):